Publications by authors named "Dunja Klein"

Claim this Profile
F
Final Results from RIBBIT: A Randomized Phase III Study to Evaluate Efficacy and Quality of Life in Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer Receiving Ribociclib in Combination with Endocrine Therapy or Chemotherapy with or without Bevacizumab in the First-Line Setting.
Thomas Decker, Matthias Zaiss, Dunja Klein, Antje Hahn, Volker Hagen

Breast Care (Basel)· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Everolimus after failure of one prior VEGF-targeted therapy in metastatic renal cell carcinoma: Final results of the MARC-2 trial.
Michael Staehler, Michael Stöckle, Daniel C Christoph, Arnulf Stenzl, Karin Potthoff, Dunja Klein

Int J Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis